Sage Journals: Discover world-class research

Open access

Research article

First published 2023-7

Methods for comparative effectiveness based on time to confirmed disability progression with irregular observations in multiple sclerosis

Thomas PA Debray, Gabrielle Simoneau, Massimiliano Copetti [...]

Statistical Methods in Medical Research

Open access

Research article

First published 2021-4

Confirmed disability progression provides limited predictive information regarding future disease progression in multiple sclerosis

Brian C Healy, Bonnie I Glanz, Elyse Swallow [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2022-9

Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years

Bruce AC Cree, Douglas L Arnold, Robert J Fox [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2017-6

Baseline EDSS proportions in MS clinical trials affect the overall outcome and power: A cautionary note

Guoqiao Wang, Gary R Cutter, Stacey S Cofield [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2025-9

Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials

Jeffrey A Cohen, Douglas L Arnold, John DeLuca [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2024

Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons

Nicholas Riley, Christopher Drudge, Morag Nelson [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2021-9

Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis

Bruce AC Cree, Baldur Magnusson, Nicolas Rouyrre [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2020-1

An exploratory analysis of the efficacy of ocrelizumab in patients with multiple sclerosis with increased disability

Jerry S Wolinsky, Natalie J Engmann, Jinglan Pei [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2017-1

The EDSS-Plus,an improved endpoint for disability progression in secondary progressive multiple sclerosis

Diego Cadavid, Jeffrey A Cohen, Mark S Freedman [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 1997-04

Intravenous immunoglobulin (IVIG) treatment for patients with primary or secondary progressive multiple sclerosis - outline of a double-blind randomized,placebo-controlled trial

D. Poehlau, J. Federlein, T. Postert [...]

Multiple Sclerosis Journal

Search results